BROOMFIELD, Colo.--(BUSINESS WIRE)--Sep 13, 2018--The latest in the series of AMPLEXOR Life Sciences ’ webinars has been announced, with a focus on Regulatory Information Management (RIM) - addressing ‘integral RIM’, the removal of risks from regulatory content changes, and focusing on RIM market trends and landscape forecasts for 2022.

Kicking off September’s webinar program is Romuald Braun, Vice President Strategy - Life Sciences, AMPLEXOR, who will present - Removing the Risks From Regulatory Content Changes: Keep Control With 'Integral RIM' - on 20 September. To achieve exceptional benefits from RIM across the entire business, it requires an enterprise-wide ability to coordinate changes to product and regulatory information, wherever content is affected. Romuald will outline the case for ‘integral RIM’, which promises true end-to-end product and regulatory insight, with reduced costs and complexity.

Continuing the RIM theme is guest presenter, Steve Gens, Managing Partner, Gens and Associates. Steve’s webinar - Evolution of Regulatory Information Management: Past, Present and RIM2022 Predictions - taking place 27 September. He will present the findings from his latest industry World Class RIM Research, provide insights on where the industry is today and what priority investments are for the next two to four years.

Steve will also cover practical advice, such as how companies can connect their RIM environment with other functional areas along with ways to help you improve your RIM program immediately.

“RIM is an ongoing challenge for almost everyone within the industry, and insight on best to approach this is always incredibly well-received,” said Elvis Paćelat, Executive Vice President, Life Sciences, AMPLEXOR. “The Gens and Associates research has become a true industry benchmark as to how organisations are approaching RIM and which technologies they are doing so with, and to get practical learnings from that will be of real benefit to all of our webinar attendees.”

20 September: The Removing the Risks from Regulatory Content Changes: Keep Control with 'Integral RIM' webinar: Session A: 9 a.m. EDT/3 p.m. CEST and Session B: 11 a.m. EDT / 5 p.m. CEST. To register for this webinar, click here.

27 September: The Evolution of Regulatory Information Management: Past, Present and RIM2022 Predictions webinar takes place on 27 September: Session A: 8:00 a.m. EDT/2 p.m. CEST and Session B: 1:30 p.m. EDT / 7:30 p.m. CEST. To register for this webinar, click here.

About the Presenters

Romuald Braun, Vice President- Strategy, Life Sciences, AMPLEXOR

Romuald has devoted his 25-year career to-date to various roles related to compliance, document management, and content management in the Life Sciences industry. He has held leadership roles both on the client side and in consulting, including delivery, sales, and project and line manager. His experiences bridge on-premise and cloud environments in Europe and the US.

Steve Gens, Managing Director of Gens and Associates, Inc.

Steve is the Managing Partner of Gens and Associates Inc., a global Life Science consulting firm that specializes in strategic planning, RIM program development and execution, industry benchmarking, and organizational performance. Gens and Associates is best known for its insightful industry benchmarks, and World Class RIM thought leadership. Steve was recently named in the PharmaVoice 100 for 2017.

About AMPLEXOR Life Sciences

AMPLEXOR Life Sciences assists organizations developing pharmaceuticals, medical devices, and biotechnology with launching products and breaking into new markets quickly. Its proven solutions as well as professional and business services expedite the creation and delivery of consistent, compliant, high-quality and global content – both physical and digital.

AMPLEXOR Life Sciences boasts a rich 25+ year history of serving pharmaceutical producers, medical device manufacturers, and biotechnology companies.

For more information, go to www.amplexor.com/lifesciences.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180913006027/en/

CONTACT: AMPLEXOR Life Sciences

Sherri Hughes-Smith, 720-557-0027

Segment Marketing Director

sherri.hughes-smith@amplexor.com

KEYWORD: UNITED STATES NORTH AMERICA COLORADO

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY MEDICAL DEVICES PHARMACEUTICAL

SOURCE: AMPLEXOR Life Sciences

Copyright Business Wire 2018.

PUB: 09/13/2018 03:49 PM/DISC: 09/13/2018 03:49 PM

http://www.businesswire.com/news/home/20180913006027/en